» Articles » PMID: 25202418

Hyperleukocytosis: A Report of Five Cases and Review of the Literature

Overview
Journal Oncol Lett
Specialty Oncology
Date 2014 Sep 10
PMID 25202418
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperleukocytosis (white blood cell count, >100×10/l), an uncommon presentation of leukemia, is associated with an increased risk of early mortality. It may present with a variety of symptoms secondary to leukostasis, a syndrome caused by the sludging of circulating leukemic blasts in the microvasculature. Adequate measures for managing this medical emergency include hydration, cytoreduction, prevention of tumor lysis and, rarely, leukapheresis in cases complicated by leukostasis and hyperviscosity syndrome. The present study reports a case series of five patients with hyperleukocytic leukemia. In addition, a review of the literature with regard to the incidence, pathophysiology, clinical manifestations and management of this laboratory abnormality is included. This study demonstrated that the central nervous system and lungs are the most common sites for leukostasis, and that emergency cases require aggressive treatment.

Citing Articles

A randomized trial of Bacteroides fragilis 839 on preventing chemotherapy-induced myelosuppression and gastrointestinal adverse effects in breast cancer patients.

Zeng T, Deng Y, Lin C, Chen X, Jia H, Hu X Asia Pac J Clin Nutr. 2024; 33(1):23-32.

PMID: 38494684 PMC: 11170005. DOI: 10.6133/apjcn.202403_33(1).0003.


Pediatric Emergency Medicine Didactics and Simulation (PEMDAS) Telesimulation Series: Hyperleukocytosis.

Koff A, Burns R, Auerbach M, Lee B, Pearce J, Ciener D MedEdPORTAL. 2021; 17:11205.

PMID: 34963902 PMC: 8666409. DOI: 10.15766/mep_2374-8265.11205.


Subjective intermittent colour vision loss as the initial presentation of chronic myeloid leukemia.

Saleh S, Esmail K, Albreiki D Am J Ophthalmol Case Rep. 2020; 19:100817.

PMID: 32695927 PMC: 7364017. DOI: 10.1016/j.ajoc.2020.100817.


Pegfilgrastim-induced hyperleukocytosis leading to hospitalization of a patient with breast cancer.

Chavda R, Herrington J Proc (Bayl Univ Med Cent). 2019; 32(2):261-262.

PMID: 31191148 PMC: 6541046. DOI: 10.1080/08998280.2018.1547873.


Oncologic Emergencies-The Old, the New, and the Deadly.

Thandra K, Salah Z, Chawla S J Intensive Care Med. 2018; 35(1):3-13.

PMID: 30411648 PMC: 6886674. DOI: 10.1177/0885066618803863.


References
1.
Dixit A, Chatterjee T, Mishra P, Kannan M, Choudhry D, Mahapatra M . Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. Clin Appl Thromb Hemost. 2007; 13(3):292-8. DOI: 10.1177/1076029607302435. View

2.
Jain R, Bansal D, Marwaha R . Hyperleukocytosis: emergency management. Indian J Pediatr. 2012; 80(2):144-8. DOI: 10.1007/s12098-012-0917-3. View

3.
Oliveira L, Romano L, Prado-Junior B, Covas D, Rego E, De Santis G . Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol. 2009; 27(4):1254-9. DOI: 10.1007/s12032-009-9367-9. View

4.
Bruserud O, Liseth K, Stamnesfet S, Cacic D, Melve G, Kristoffersen E . Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfus Med. 2013; 23(6):397-406. DOI: 10.1111/tme.12067. View

5.
Ganzel C, Becker J, Mintz P, Lazarus H, Rowe J . Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012; 26(3):117-22. DOI: 10.1016/j.blre.2012.01.003. View